Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

130.75INR
31 Aug 2015
Change (% chg)

Rs-5.25 (-3.86%)
Prev Close
Rs136.00
Open
Rs140.95
Day's High
Rs140.95
Day's Low
Rs128.95
Volume
101,894
Avg. Vol
63,257
52-wk High
Rs219.35
52-wk Low
Rs99.10

PNCA.NS

Chart for PNCA.NS

About

Panacea Biotec Ltd is an India-based pharmaceutical company. The Company’s businesses include biologicals, pharmaceuticals formulation, research & development. Panacea Biotec has brand equity in branded pharmaceutical formulations including Oncology, Nephrology, Organ Transplant, Pain Management, and Diabetes Management. The... (more)
No analyst recommendations are available for PNCA.NS.

Overall

Beta: 0.86
Market Cap(Mil.): Rs8,330.10
Shares Outstanding(Mil.): 61.25
Dividend: --
Yield (%): --

Financials

  PNCA.NS Industry Sector
P/E (TTM): -- 35.90 36.13
EPS (TTM): -- -- --
ROI: -- 15.37 14.83
ROE: -- 15.94 15.69
Search Stocks

BRIEF-Demire purchases interests in management companies

May 27 - Demire Deutsche Mittelstand Real Estate AG : * Acquired a 51 percent interest in asset management company Panacea Property GmbH * Says also acquired 51 percent interest in facility management company Praedia Haus & Gartenservice GmbH * Says the parties to the transaction have agreed not to disclose the purchase

27 May 2015

Earnings vs. Estimates

Search Stocks